U.S. markets open in 6 hours 50 minutes
  • S&P Futures

    3,984.25
    +6.25 (+0.16%)
     
  • Dow Futures

    32,365.00
    +46.00 (+0.14%)
     
  • Nasdaq Futures

    12,872.25
    +18.25 (+0.14%)
     
  • Russell 2000 Futures

    1,740.50
    +8.00 (+0.46%)
     
  • Crude Oil

    69.96
    0.00 (0.00%)
     
  • Gold

    1,989.60
    -6.30 (-0.32%)
     
  • Silver

    23.15
    -0.11 (-0.48%)
     
  • EUR/USD

    1.0833
    -0.0004 (-0.03%)
     
  • 10-Yr Bond

    3.4060
    0.0000 (0.00%)
     
  • Vix

    22.61
    +0.35 (+1.57%)
     
  • GBP/USD

    1.2278
    -0.0011 (-0.09%)
     
  • USD/JPY

    130.3300
    -0.4590 (-0.35%)
     
  • Bitcoin USD

    28,304.14
    +586.96 (+2.12%)
     
  • CMC Crypto 200

    618.60
    +21.14 (+3.54%)
     
  • FTSE 100

    7,499.60
    -67.24 (-0.89%)
     
  • Nikkei 225

    27,385.25
    -34.36 (-0.13%)
     

AstraZeneca Has a Covid Sales Problem. Its Stock Doesn’t.

AstraZeneca Has a Covid Sales Problem. Its Stock Doesn’t.

The Anglo-Swedish pharma major reported 1% revenue growth as cancer and cardiovascular therapies offset a decline in sales of its Vaxzevria vaccine.